Jovaro laboratorija - Company finances
|
EUR
|
2019
From: 2019-03-08
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 15,476 | 14,174 | 38,236 | 101,341 | 168,843 | 154,852 | 139,396 |
| Profit before tax | 4,748 | 2,879 | 15,548 | 22,505 | 39,219 | 11,169 | 212 |
| Net profit | 4,748 | 2,705 | 14,750 | 21,380 | 37,199 | 10,447 | 2 |
| Equity | 4,848 | 7,553 | 22,303 | 43,683 | 80,882 | 72,329 | 43,831 |
| Liabilities | - | - | - | 8,012 | 27,222 | 22,772 | 13,326 |
| Non-current assets | 0 | 0 | 6,140 | 9,180 | 56,037 | 44,750 | 37,923 |
| Current assets | 5,475 | 8,622 | 17,579 | 42,515 | 52,067 | 50,351 | 19,234 |
| Total assets | 5,475 | 8,622 | 23,719 | 51,695 | 108,104 | 95,101 | 57,157 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 1,143 | 2,064 | 722 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | -8.4% | +169.8% | +165.0% | +66.6% | -8.3% | -10.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 86.7% | 31.4% | 62.2% | 41.4% | 34.4% | 11.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 97.9% | 35.8% | 66.1% | 48.9% | 46.0% | 14.4% | 0.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 30.7% | 19.1% | 38.6% | 21.1% | 22.0% | 6.7% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 30.7% | 20.3% | 40.7% | 22.2% | 23.2% | 7.2% | 0.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.2 | 0.3 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Jovaro laboratorija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-07-19 | 2023-07-31 | 799.74 |
Jovaro laboratorija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-19 | 2026-07-07 | 0.18 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Jovaro laboratorija, MB (code 305065510) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In the latest financial year, 2025, the company generated revenue of €139.4K, down 10.0% year on year and 17.4% below the 2023 level. Net profit for 2025 was €2, with a profit margin of 0.0%, showing that profitability weakened sharply from €10.4K in 2024 and €37.2K in 2023. The three-year trend points to a steady contraction in both turnover and earnings. The balance sheet also narrowed over the period: total assets fell to €57.2K in 2025 from €95.1K in 2024 and €108.1K in 2023. Equity decreased to €43.8K, while liabilities were €13.3K. The company’s equity ratio was 76.7%, debt-to-equity stood at 0.30, and asset turnover reached 2.44x in 2025. Long-term assets were €37.9K and short-term assets €19.2K.